Clinical activity of P-BCMA-ALLO1, a B-cell maturation antigen (BCMA) targeted allogeneic chimeric antigen receptor T-cell (CAR-T) therapy, in relapsed refractory multiple myeloma (RRMM) patients (pts) following progression on prior BCMA targeting therapy

被引：2
|
作者：
Dholaria, Bhagirathbhai
Shune, Leyla
Kin, Andrew
McArthur, Katherine
Eskew, Jeff D.
Martin, Christopher E.
Haag, Sabrina
McCaigue, Joanne
Namini, Hamid
DePrimo, Sam
Cranert, Stacey
Coronella, Julia
Shedlock, Devon
Belani, Rajesh
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2024-CT071
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT071
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [1] Early Safety Results of P-BCMA-ALLO1, a Fully Allogeneic Chimeric Antigen Receptor T-Cell (CAR-T), in Patients with Relapsed / Refractory Multiple Myeloma (RRMM)
    Dholaria, Bhagirathbhai
    Kocoglu, Mehmet H.
    Kin, Andrew
    Asch, Adam S.
    Ramakrishnan, Aravind
    Bachier, Carlos
    Rodriguez, Tulio E.
    Shune, Leyla
    McArthur, Katherine
    McCaigue, Joanne
    DePrimo, Samuel
    Martin, Chris
    Haag, Sabrina
    Zhang, Maggie
    Namini, Hamid
    Christie, Ellen
    Belani, Rajesh
    Cranert, Stacey A.
    Coronella, Julia
    Shedlock, Devon J.
    Costello, Caitlin L.
    BLOOD, 2023, 142
  • [2] Chimeric Antigen Receptor-T (CAR-T) Cell Therapy Targeting BCMA in Patients with Prior Allogeneic Transplantation (allo-HCT) in Relapsed and/or Refractory Multiple Myeloma (RRMM)
    Hammons, Lindsay
    Haider, Shabi
    Pasquini, Marcelo C.
    Chhabra, Saurabh
    Radhakrishnan, Sabarinath
    Zamora, Anthony E.
    Mohan, Meera
    Dong, Jing
    Janz, Siegfried
    D'Souza, Anita
    Hari, Parameswaran
    Dhakal, Binod
    BLOOD, 2022, 140 : 7215 - 7216
  • [3] BCMA-targeting chimeric antigen receptor T cell therapy for relapsed and/or refractory multiple myeloma
    Fang, Jiamin
    Zhou, Fuling
    ANNALS OF HEMATOLOGY, 2024, 103 (04) : 1069 - 1083
  • [4] Updated Results of Ciltacabtagene Autoleucel (Cilta-Cel), a B-Cell Maturation Antigen (BCMA)-Directed Chimeric Antigen Receptor T (CAR-T) Cell Therapy in Relapsed/Refractory Multiple Myeloma (RRMM)
    Usmani, Saad Z.
    Berdeja, Jesus G.
    Madduri, Deepu
    Jakubowiak, Andrzej
    Agha, Mounzer
    Cohen, Adam D.
    Hari, Parameswaran
    Yeh, Tzu-Min
    Olyslager, Yunsi
    Banerjee, Arnob
    Jackson, Carolyn C.
    Allred, Alicia
    Zudaire, Enrique
    Deraedt, William
    Wu, Xiaoling
    Carrasco-Alfonso, Marlene J.
    Akram, Muhammad
    Lin, Yi
    Martin, Thomas
    Jagannath, Sundar
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S422 - S423
  • [5] BCMA-targeting chimeric antigen receptor T-cell therapy for multiple myeloma
    Yang, Jinrong
    Zhou, Weilin
    Li, Dan
    Niu, Ting
    Wang, Wei
    CANCER LETTERS, 2023, 553
  • [6] Incidence and Risk Factors Associated With Bleeding Following Anti-B-Cell Maturation Antigen (BCMA) Chimeric Antigen Receptor (CAR) T-Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma (RRMM)
    Mohammed, Turab
    Peres, Lauren
    Colinleitzinger, Christelle
    Puglianini, Omar Castaneda
    Oswald, Laura
    De Avila, Gabe
    Grajales-Cruz, Ariel
    Blue, Brandon
    Ochoa-Bayona, Jose
    Khimani, Farhad
    Faramand, Rawan
    Elmariah, Hany
    Lazaryan, Aleksandr
    Jain, Michael
    Liu, Hein
    Nishihori, Taiga
    Shain, Ken
    Baz, Rachid
    Alsina, Melissa
    Locke, Frederick
    Freeman, Ciara
    Hansen, Doris
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S473 - S474
  • [7] Ciltacabtagene autoleucel CAR-T therapy targeting B-cell maturation antigen (BCMA) Treatment of multiple myeloma
    Lee, Sarah
    Cowan, Andrew J.
    DRUGS OF THE FUTURE, 2022, 47 (04) : 233 - 238
  • [8] B- Cell Maturation Antigen (BCMA) Re-Emergence and Relapse Patterns Post-BCMA-Chimeric Antigen Receptor T Cell (CAR-T) Therapy for Multiple Myeloma
    Wesson, William
    Cui, Wei
    Mushtaq, Muhammad
    Bansal, Rajat
    Singh, Anurag K.
    Hoffmann, Marc
    Tun, Aung M.
    Balusu, Ramesh
    Abdelhakim, Haitham
    Abhyankar, Sunil H.
    McGuirk, Joseph P.
    Shune, Leyla O.
    Abdallah, Al-Ola
    Ahmed, Nausheen
    BLOOD, 2022, 140 : 12781 - 12783
  • [9] CAR-T-Cell Therapy in Multiple Myeloma: B-Cell Maturation Antigen (BCMA) and Beyond
    Mishra, Abhinava K.
    Gupta, Ashna
    Dagar, Gunjan
    Das, Dayasagar
    Chakraborty, Abhijit
    Haque, Shabirul
    Prasad, Chandra Prakash
    Singh, Archana
    Bhat, Ajaz A.
    Macha, Muzafar A.
    Benali, Moez
    Saini, Kamal S.
    Previs, Rebecca Ann
    Saini, Deepak
    Saha, Dwaipayan
    Dutta, Preyangsee
    Bhatnagar, Aseem Rai
    Darswal, Mrinalini
    Shankar, Abhishek
    Singh, Mayank
    VACCINES, 2023, 11 (11)
  • [10] Associations of T-cell fitness prior to B-cell maturation antigen (BCMA)-targeted chimeric antigen receptor T-cell (CART) and bispecific T-cell engager (BiTE) therapies and efficacy/toxicity in relapsed/refractory multiple myeloma (RRMM)
    Theprungsirikul, Poy
    Yu, Mansen
    Rall, Kerri
    Matthews, Martin
    Neparidze, Natalia
    Parker, Terri L.
    Browning, Sabrina
    Anderson, Tara
    Stevens, Erica
    Foss, Francine M.
    Gowda, Lohith
    Pillai, Manoj
    Isufi, Iris
    Seropian, Stuart
    Mirza, Sayeef
    Bar, Noffar
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345